AusPAR: Nivolumab

Australian Public Assessment Report

AusPAR

AusPAR: Nivolumab [Opdivo] [PDF, 850.01 KB]

AusPAR: Nivolumab [Opdivo] [Word, 967.39 KB]

Attachment: Product Information: Nivolumab [Opdivo] [PDF, 711.46 KB]

Attachment: Product Information: Nivolumab [Opdivo] [Word, 1.42 MB]

Attachment: Extract from Clinical Evaluation Report: ENivolumab [Opdivo] [PDF, 4.27 MB]

Attachment: Extract from Clinical Evaluation Report: ENivolumab [Opdivo] [Word, 7.72 MB]

Device/Product Name

Opdivo

Active ingredients

Nivolumab

AusPAR Date

31 October 2017

Published

9 November 2017

Submission Number

PM-2016-0712-1-4

Submission Type

Extension of indications

Decision

Approved